Clinical research leads to innovation and success
"Observed risk reduction of radiation dermatitis with the use of StrataXRT"23
Raymond Chan, RN, PhD, GAICD, Queensland University of Technology, Brisbane, Australia discussing the prevention and management of radiation dermatitis using StrataXRT:
A single-blind, randomised controlled trial of StrataXRT® - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer
Chan et al. (2019)
Radiotherapy and Oncology
“This RCT is the first trial to yield significant, positive effects of non-steroidal topical preparation for radiation dermatitis in patients with head & neck cancer.”
“StrataXRT is superior to standard care in preventing, delaying, and reducing severity of skin toxicity.”
“First time evidence of improving the RISRAS skin toxicity score during ongoing radiation therapy, showing major improvements in patients’ quality of life”
“85% of the assessors rated StrataXRT as an improvement compared to standard clinical practice in treatment of radiation dermatitis”
Reducing radiation dermatitis during ongoing radiation therapy:an innovative film-forming wound dressing
Quilis A. et. al. (2018)
Journal of Radiation Oncology
Does the use of StrataXRT prevent moist desquamation in NMSC patients treated with superficial radiation therapy in the head & neck area?
Ahn S. (2020)
InVivo journal
“First RCT demonstrating superiority of StrataXRT in reducing radiation dermatitis during breast radiation based on objectively measured physiological skin parameters”
“First time evidence of reducing severity of acute cutaneous reactions during ongoing radiation therapy with concomitant chemotherapy”
Radiation induced skin reactions: is StrataXRT more effective in the prevention and management of Radiation induced skin reactions (RISR) than standard care?
Arranz and Gonzalez (2018)
Journal of Cancer Therapy
StrataXRT is non inferior to Mepitel Film in preventing Radiation Induced Moist Desquamation
Chao M. et al. (2019)
European Society for Radiotherapy and Oncology
“StrataXRT was not inferior to Mepitel Film on the reported outcome measures of occurrence of moist desquamation, worst grade of acute radiation dermatitis (ARD) and time weighted average (TWA) grade of ARD over 10 weeks.”
“Mepitel Film further extended the utilization of scarce nursing resource which may make StrataXRT a more pragmatic choice.”
“This study provides the first cost-effectiveness analysis undertaken measuring resources used to prevent and manage radiation dermatitis from a healthcare provider perspective.”
“StrataXRT prevented Grade 3 radiation dermatitis for patients with head and neck cancer but was more costly than Sorbolene.”
Cost-effectiveness of StrataXRT vs Sorbolene for radiodermatitis in head and neck cancer patients: a trial-based economic evaluation
Blades R., Chan RJ., Yates P., McPhail S. (2019)
Oncology Nursing Conference
Does the use of StrataXRT prevent moist desquamation in NMSC patients treated with superficial radiation therapy in the head & neck area?
Smee R., Bissell N., Malcolm N. (2015)
World Congress on Larynx cancer
“using this silicone gel for the prevention and treatment of radiation dermatitis, showed low reactionary scores with minimal radiation dermatitis compared to our observed standard. RTOG 3 was completely prevented in the StrataXRT group.”
“Providing one large tube of StrataXRT is likely to be cost-effective in preventing Grade 3 radiation dermatitis.”
Radiation induced skin reactions: is StrataXRT more effective in the prevention and management of Radiation induced skin reactions (RISR) than standard care?
Ford C. (2017)
Mid North Coast Cancer Institute (MNCCI) & Mid North Coast LHD, Coffs Harbour NSW